Possible involvement of μ opioid receptor in the antidepressant-like effect of Shuyu formula in restraint stress-induced depression-like rats

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Wang, Fu Rong ^a   Qiao, Ming Qi ^a   Xue, Ling ^a   Wei, Sheng ^a  

^a SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; HERBACEOUS AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MU OPIATE RECEPTOR; SHUYU; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BINDING SITE; BODY WEIGHT; CHINESE MEDICINE; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FEMALE; FORCED SWIM TEST; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMOBILITY; IMMOBILIZATION STRESS; LOCOMOTION; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REARING; SIGNAL TRANSDUCTION; SQUARE CROSSING; UPREGULATION; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84925400452     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/452412     Document Type: Article

References (37)

1. C. D. Mathers and D. Loncar, "Projections of global mortality and burden of disease from 2002 to 2030, " PLoS Medicine, vol. 3, no. 11, article e442, 2006.
2. M. H. Trivedi, A. J. Rush, S. R. Wisniewski et al. , "Evaluation of outcomes with citalopram for depression using measurementbased care in STAR∗D: implications for clinical practice, " The American Journal of Psychiatry, vol. 163, no. 1, pp. 28-40, 2006.
3. S. E. Kennedy, R. A. Koeppe, E. A. Young, and J.-K. Zubieta, "Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women, " Archives of General Psychiatry, vol. 63, no. 11, pp. 1199-1208, 2006.
4. G. Swann, G. R. Byck, D. M. Dick et al. , "Effect of OPRM1 and stressful life events on symptoms ofmajor depression inAfrican American adolescents, " Journal of Affective Disorders, vol. 162, pp. 12-19, 2014.
5. H. A. Garriock, M. Tanowitz, J. B. Kraft et al. , "Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder, " American Journal of Psychiatry, vol. 167, no. 5, pp. 565-573, 2010.
6. S. Ide, S. Fujiwara, M. Fujiwara et al. , "Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockoutmice, " Journal of Pharmacological Sciences, vol. 114, no. 1, pp. 107-110, 2010.
7. E. Berrocoso, K. Ikeda, I. Sora, G. R. Uhl, P. Sanchez-Blazquez, and J. A. Mico, "Active behaviours produced by antidepressants and opioids in the mouse tail suspension test, " International Journal of Neuropsychopharmacology, vol. 16, no. 1, pp. 151-162, 2013.
8. M. M. Gassaway, M.-L. Rives, A. C. Kruegel, J. A. Javitch, andD. Sames, "The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist, " Translational Psychiatry, vol. 4, article e411, 2014.
9. J. Sarris, A. Panossian, I. Schweitzer, C. Stough, and A. Scholey, "Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence, " European Neuropsychopharmacology, vol. 21, no. 12, pp. 841-860, 2011.
10. D. Dhingra and A. Sharma, "Antidepressant-like activity of Glycyrrhiza glabra L. inmousemodels of immobility tests, " Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 30, no. 3, pp. 449-454, 2006.
11. L. Bombi, H. Y. Yun, I. Shim, H. Lee, andD.-H. Hahm, "Bupleurumfalcatumprevents depression and anxiety-like behaviors in rats exposed to repeated restraint stress, " Journal ofMicrobiology and Biotechnology, vol. 22, no. 3, pp. 422-430, 2012.
12. F. Qiu, X. Zhong, Q. Mao, and Z. Huang, "The antidepressantlike effects of paeoniflorin in mouse models, " Experimental and Therapeutic Medicine, vol. 5, no. 4, pp. 1113-1116, 2013.
13. Z. L. Zhou and Y. H. Liu, "Study on antidepressant effect and mechanism by cyperus rotundus extracts, " Chinese Journal of Experimental TraditionalMedical Formulae, vol. 18, pp. 191-193, 2012.
14. Q. Tan and H. Y. Zhang, "Effect of Shuyu Capsule on location and expression of 5-hydroxy tryptamine 3B receptor in hippocampus and hypothalamus regions in rats with depression emotion, " Chinese Journal of Experimental Traditional Medical Formulae, vol. 17, pp. 137-140, 2011.
15. A. E. Freitas, L. E. B. Bettio, V. B. Neis et al. , "Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice, " Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 50, pp. 143-150, 2014.
16. S. H. Yoon, B.-H. Kim, S.-K. Ye, and M.-H. Kim, "Chronic non-social stress affects depressive behaviors but not anxiety in mice, " The Korean Journal of Physiology and Pharmacology, vol. 18, no. 3, pp. 263-268, 2014.
17. L. Guan, N. Jia, X. Zhao et al. , "The involvement of ERK/ CREB/Bcl-2 in depression-like behavior in prenatally stressed offspring rats, " Brain Research Bulletin, vol. 99, pp. 1-8, 2013.
18. S. M. Gibney, E. M. Fagan, A.-M. Waldron, J. OByrne, T. J. Connor, and A. Harkin, "Inhibition of stress-induced hepatic tryptophan 2, 3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour, " International Journal of Neuropsychopharmacology, vol. 17, no. 6, pp. 917-928, 2014.
19. B. Xing, P. Liu, W.-H. Jiang et al. , "Effects of immobilization stress on emotional behaviors in dopamine D3 receptor knockout mice, " Behavioural Brain Research, vol. 243, no. 1, pp. 261-266, 2013.
20. J. McHenry, N. Carrier, E. Hull, and M. Kabbaj, "Sex differences in anxiety and depression: role of testosterone, " Frontiers in Neuroendocrinology, vol. 35, no. 1, pp. 42-57, 2014.
21. Q.-Z. Yang, S.-S. Lu, X.-Z. Tian, A.-M. Yang, W.-W. Ge, and Q. Chen, "The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice, " Neuroscience Letters, vol. 489, no. 2, pp. 131-135, 2011.
22. J. I.-H. Yoo, S.-Y. Lee, H. H. Loh, I. K. Ho, and C.-G. Jang, "Altered emotional behaviors and the expression of 5-HT1A and M1 muscarinic receptors in μ-opioid receptor knockout mice, " Synapse, vol. 54, no. 2, pp. 72-82, 2004.
23. S. Ide, I. Sora, K. Ikeda, M. Minami, G. R. Uhl, and K. Ishihara, "Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice, " Neuropharmacology, vol. 58, no. 1, pp. 241-247, 2010.
24. H. Komatsu, A. Ohara, K. Sasaki et al. , "Decreased response to social defeat stress in μ-opioid-receptor knockout mice, " Pharmacology Biochemistry and Behavior, vol. 99, no. 4, pp. 676-682, 2011.
25. K. L. Gonzales, J. D. Chapleau, J. P. Pierce et al. , "The influences of reproductive status and acute stress on the levels of phosphorylated mu opioid receptor immunoreactivity in rat hippocampus, " Frontiers in Endocrinology, vol. 2, article 18, 2010.
26. M. Yamamoto, T. Komori, T. Matsumoto et al. , "Effects of single and repeated prolonged stress on mu-opioid receptor mRNA expression in rat gross hypothalamic and midbrain homogenates, " Brain Research, vol. 980, no. 2, pp. 191-196, 2003.
27. P. V. Escriba, A. Ozaita, and J. A. Garcia-Sevilla, "Increased mRNA expression of α2A-adrenoceptors, serotonin and receptors and μ-opioid receptors in the brains of suicide victims, " Neuropsychopharmacology, vol. 29, no. 8, pp. 1512-1521, 2004.
28. C. Giaroni, L. Canciani, E. Zanetti et al. , "Effects of chronic desipramine treatment on alpha2-adrenoceptors and muopioid receptors in the guinea pig cortex and hippocampus, " European Journal of Pharmacology, vol. 579, no. 1-3, pp. 116-125, 2008.
29. F. Chen and A. J. Lawrence, "Chronic antidepressant treatment causes a selective reduction of μ-opioid receptor binding and functional coupling to G proteins in the amygdala of Fawn-Hooded rats, " Journal of Pharmacology and Experimental Therapeutics, vol. 310, no. 3, pp. 1020-1026, 2004.
30. P. Pallavi, R. Sagar, M. Mehta et al. , "Serumneurotrophic factors in adolescent depression: gender difference and correlation with clinical severity, " Journal ofAffectiveDisorders, vol. 150, no. 2, pp. 415-423, 2013.
31. O. M. Wolkowitz, J. Wolf, W. Shelly et al. , "Serum BDNF levels before treatment predict SSRI response in depression, " Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 7, pp. 1623-1630, 2011.
32. L. Jin, F. Wu, X. Li et al. , "Anti-depressant effects of aqueous extract from Acanthopanax senticosus in mice, " Phytotherapy Research, vol. 27, no. 12, pp. 1829-1833, 2013.
33. S.-W. Lim, S. Kim, B. J. Carroll, and D. K. Kim, "T-lymphocyte CREB as a potential biomarker of response to antidepressant drugs, " International Journal of Neuropsychopharmacology, vol. 16, no. 5, pp. 967-974, 2013.
34. H. Qi, F. Mailliet, M. Spedding et al. , "Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation, " Neuropharmacology, vol. 56, no. 1, pp. 37-46, 2009.
35. J.-R. Kuo, Y.-H. Cheng, Y.-S. Chen, C.-C. Chio, and P.-W. Gean, "Involvement of extracellular signal regulated kinases in traumatic brain injury-induced depression in rodents, " Journal of Neurotrauma, vol. 30, no. 14, pp. 1223-1231, 2013.
36. K. Takano, H. Yamasaki, K. Kawabe, M. Moriyama, and Y. Nakamura, "Imipramine induces brain-derived neurotrophic factor mRNA expression in cultured astrocytes, " Journal of Pharmacological Sciences, vol. 120, no. 3, pp. 176-186, 2012.
37. P. Cruz Duarte, B. St-Jacques, and W. Ma, "Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model, " Experimental Neurology, vol. 234, no. 2, pp. 466-481, 2012.